The Diagnostic Imaging staff is suspending its Webnews coverage during the week of December 26. Coverage will resume on Jan. 3. Best wishes for the holidays and the year ahead.
The Diagnostic Imaging >
staff is suspending its Webnews coverage during the week of December 26. Coverage will resume on Jan. 3. Best wishes for the holidays and the year ahead.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.